Search research articles
Contact Us
Filters
Showing results (331-340 of 357) with videos related to
Page
of 36
Sort By:
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
Ira M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.
American Journal of Hematology
|
November 6, 2020
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Veronica Guerra, et al.
Blood
|
December 23, 2016
Long-term outcome of acute promyelocytic leukemia treated with all-<i>trans</i>-retinoic acid, arsenic trioxide, and gemtuzumab
Yasmin Abaza, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood Advances
|
March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
Alexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
Leukemia
|
May 19, 2021
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations
Nitin Jain, Philip Thompson, Jan Burger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Haematologica
|
December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasms
Jayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
The Lancet. Haematology
|
November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Cardiology and Therapy
|
November 6, 2024
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
Uday M Jadhav, Saumitra Ray, T Govindan Unni, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 357) with videos related to
Sort By:
Page
of 36
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
Ira M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.
American Journal of Hematology
|
November 6, 2020
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Veronica Guerra, et al.
Blood
|
December 23, 2016
Long-term outcome of acute promyelocytic leukemia treated with all-<i>trans</i>-retinoic acid, arsenic trioxide, and gemtuzumab
Yasmin Abaza, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood Advances
|
March 8, 2023
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
Alexandre Bazinet, Tapan Kadia, Nicholas J Short, et al.
Leukemia
|
May 19, 2021
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations
Nitin Jain, Philip Thompson, Jan Burger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Haematologica
|
December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasms
Jayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
The Lancet. Haematology
|
November 19, 2022
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Cardiology and Therapy
|
November 6, 2024
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
Uday M Jadhav, Saumitra Ray, T Govindan Unni, et al.
Page
of 36